SOUTH SAN FRANCISCO, Calif., January 12, 2026--insitro, the AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro’s TherML™ ...
Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled. NEW YORK, Sept. 26, 2024 /PRNewswire/ -- In a first-of-a-kind collaboration, Target ALS, a ...
Conversation is a well-established diagnostic tool. For disorders such as Parkinson’s disease and amyotrophic lateral sclerosis, patient assessments include interviews during which observations are ...
The productivity upside is straightforward. Research, like the Stanford report linked above, has repeatedly shown that ...
Dublin, May 09, 2024 (GLOBE NEWSWIRE) -- The "Global Generative AI Market by Offering (Transformer Models (GPT-1, GPT-2, GPT-3, GPT-4, LaMDA), Services), Modality ...